Loading clinical trials...

Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT05273762

Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever

This study is focused on investigating the efficacy and safety of the FlowTriever device to treat low-risk submassive pulmonary embolism.

Lead sponsor: Northwell Health•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Victoria Roselli, Clinical Research Coordinator

CONTACT

212-434-3695 vroselli@northwell.edu

Sponsors

Lead Sponsor

Northwell Health

Collaborators

Inari Medical

Related studies

Data Clustering Study With Artificial Intelligence and Phenotyping of Patients With Acute Pulmonary Embolism

NCT06183944 · Pulmonary Embolism

CLEANer Aspiration for Pulmonary Embolism

NCT06189313 · Pulmonary Embolism, Acute Pulmonary Embolism, and more

Early Catheter-directed Treatment of High Risk Pulmonary Embolism

NCT06672081 · Pulmonary Embolism Acute Massive

Interest of the Chair Lift Test in the Prognostic Evaluation of Pulmonary Embolism: a Single-center Open Prospective Study

NCT06166329 · Non-severe Pulmonary Embolism, Pulmonary Embolism, and more

Saline Contrast Electrical Impedance Tomography Method for Diagnosis of Acute Pulmonary Embolism

NCT07190079 · Acute Pulmonary Embolism

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 28, 2023Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment30

Start dateJan 2022

Last updatedDec 28, 2023

Condition

Pulmonary Embolism

Locations shown

Northern Westchester Hospital

Mount Kisco, New York

Lenox Hill Hospital

New York, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 28, 2023Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions